Annual D&A
$4.17 M
+$1.47 M+54.60%
December 31, 2023
Summary
- As of February 8, 2025, MXCT annual depreciation & amortization is $4.17 million, with the most recent change of +$1.47 million (+54.60%) on December 31, 2023.
- During the last 3 years, MXCT annual D&A has risen by +$3.12 million (+298.11%).
- MXCT annual D&A is now at all-time high.
Performance
MXCT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.07 M
-$15.00 K-1.39%
September 30, 2024
Summary
- As of February 8, 2025, MXCT quarterly depreciation & amortization is $1.07 million, with the most recent change of -$15.00 thousand (-1.39%) on September 30, 2024.
- Over the past year, MXCT quarterly D&A has dropped by -$15.00 thousand (-1.39%).
- MXCT quarterly D&A is now -4.05% below its all-time high of $1.11 million, reached on March 31, 2024.
Performance
MXCT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$4.36 M
-$15.00 K-0.34%
September 30, 2024
Summary
- As of February 8, 2025, MXCT TTM depreciation & amortization is $4.36 million, with the most recent change of -$15.00 thousand (-0.34%) on September 30, 2024.
- Over the past year, MXCT TTM D&A has increased by +$371.30 thousand (+9.31%).
- MXCT TTM D&A is now -0.34% below its all-time high of $4.38 million, reached on June 30, 2024.
Performance
MXCT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
MXCT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.6% | -1.4% | +9.3% |
| 3 y3 years | +298.1% | +15.9% | +61.6% |
| 5 y5 years | +1112.5% | +15.9% | +61.6% |
MXCT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +192.9% | -4.0% | +155.9% | -0.3% | +206.2% |
| 5 y | 5-year | at high | +579.9% | -4.0% | +237.4% | -0.3% | +1280.2% |
| alltime | all time | at high | +4433.7% | -4.0% | +237.4% | -0.3% | +1280.2% |
MaxCyte Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.07 M(-1.4%) | $4.36 M(-0.3%) |
| Jun 2024 | - | $1.08 M(-2.7%) | $4.38 M(+1.3%) |
| Mar 2024 | - | $1.11 M(+0.8%) | $4.32 M(+3.6%) |
| Dec 2023 | $4.17 M(+54.6%) | $1.10 M(+1.9%) | $4.17 M(+4.6%) |
| Sep 2023 | - | $1.08 M(+5.4%) | $3.99 M(+9.2%) |
| Jun 2023 | - | $1.03 M(+6.7%) | $3.65 M(+15.1%) |
| Mar 2023 | - | $962.00 K(+4.6%) | $3.17 M(+17.6%) |
| Dec 2022 | $2.70 M(+89.5%) | $919.70 K(+23.7%) | $2.70 M(+22.9%) |
| Sep 2022 | - | $743.30 K(+35.7%) | $2.19 M(+20.8%) |
| Jun 2022 | - | $547.60 K(+12.4%) | $1.82 M(+13.9%) |
| Mar 2022 | - | $487.40 K(+17.0%) | $1.60 M(+12.0%) |
| Dec 2021 | $1.42 M | $416.50 K(+13.8%) | $1.42 M(+41.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $366.00 K(+12.4%) | $1.01 M(+57.1%) |
| Jun 2021 | - | $325.50 K(+3.0%) | $641.40 K(+103.0%) |
| Mar 2021 | - | $315.90 K | $315.90 K |
| Dec 2020 | $1.05 M(+70.8%) | - | - |
| Dec 2019 | $613.50 K(+78.3%) | - | - |
| Dec 2018 | $344.00 K(+140.7%) | - | - |
| Dec 2017 | $142.90 K(+35.2%) | - | - |
| Dec 2016 | $105.70 K(+13.3%) | - | - |
| Dec 2015 | $93.30 K(+1.4%) | - | - |
| Dec 2014 | $92.00 K(-21.0%) | - | - |
| Dec 2013 | $116.40 K(+1.0%) | - | - |
| Dec 2012 | $115.20 K | - | - |
FAQ
- What is MaxCyte annual depreciation & amortization?
- What is the all time high annual D&A for MaxCyte?
- What is MaxCyte annual D&A year-on-year change?
- What is MaxCyte quarterly depreciation & amortization?
- What is the all time high quarterly D&A for MaxCyte?
- What is MaxCyte quarterly D&A year-on-year change?
- What is MaxCyte TTM depreciation & amortization?
- What is the all time high TTM D&A for MaxCyte?
- What is MaxCyte TTM D&A year-on-year change?
What is MaxCyte annual depreciation & amortization?
The current annual D&A of MXCT is $4.17 M
What is the all time high annual D&A for MaxCyte?
MaxCyte all-time high annual depreciation & amortization is $4.17 M
What is MaxCyte annual D&A year-on-year change?
Over the past year, MXCT annual depreciation & amortization has changed by +$1.47 M (+54.60%)
What is MaxCyte quarterly depreciation & amortization?
The current quarterly D&A of MXCT is $1.07 M
What is the all time high quarterly D&A for MaxCyte?
MaxCyte all-time high quarterly depreciation & amortization is $1.11 M
What is MaxCyte quarterly D&A year-on-year change?
Over the past year, MXCT quarterly depreciation & amortization has changed by -$15.00 K (-1.39%)
What is MaxCyte TTM depreciation & amortization?
The current TTM D&A of MXCT is $4.36 M
What is the all time high TTM D&A for MaxCyte?
MaxCyte all-time high TTM depreciation & amortization is $4.38 M
What is MaxCyte TTM D&A year-on-year change?
Over the past year, MXCT TTM depreciation & amortization has changed by +$371.30 K (+9.31%)